SCT200 Injection in Patients With Head and Neck Squamous Cell Carcinoma

Condition:   Head and Neck Squamous Cell Carcinoma
Intervention:   Drug: Anti-EGFR monoclonal antibody
Sponsor:   Shi Yuankai
Not yet recruiting

https://ift.tt/2qQWqfo